Analysis of the Effect of Human Interferon α1b Aerosol Inhalation Combined with Conventional Treatment on Young Children with Respiratory Syncytial Virus Infection Pneumonia
Hou Shuangshuang, Qin Huijuan, Zhang Xiaoxiao
Department of Pediatrics,Shangqiu Municipal Hospital,Shangqiu,Henan 476000,China
Abstract：Objective To explore the application effect of human interferon α1b(IFN-α1b) aerosol inhalation combined with conventional therapy for young children with respiratory syncytial virus(RSV)-infected pneumonia. Methods A total of 82 children with RSV-infected pneumonia were randomLy selected as research samples and randomLy separated into two groups according to the digital table method.The conventional group adopted conventional treatment,and the aerosol group was treated with IFN-α1b aerosol inhalation on the basis of conventional treatment.The clinical efficacy,duration of symptom subsidence,time required for white blood cell count to return to normal,length of hospital stay,C-reactive protein(CRP) and incidence of adverse reactions between the two groups were compared. Results The clinical efficacy of the nebulizer group was higher than that of the conventional group,and the duration of symptom subsidence,the time required for the white blood cell count to return to normal,and the length of hospital stay were all lower than those of the conventional group(P<0.05).After 6 days of treatment,the CRP level of the nebulizer group was also lower than that of the conventional group(P<0.05).No notable disparity was observed in the occurrence of adverse reactions between the two groups(P>0.05). Conclusion IFN-α1b nebulizer inhalation can effectively relieve symptoms,improve inflammatory status,and has high safety,which can provide a reference for the formulation of treatment strategies for children with RSV-infected pneumonia in clinical practice.
侯双双, 秦慧娟, 张晓晓. 人干扰素α1b雾化吸入联合常规治疗对低龄呼吸道合胞病毒感染肺炎患儿的效果分析[J]. 哈尔滨医药, 2025, 45(5): 41-43.
Hou Shuangshuang, Qin Huijuan, Zhang Xiaoxiao. Analysis of the Effect of Human Interferon α1b Aerosol Inhalation Combined with Conventional Treatment on Young Children with Respiratory Syncytial Virus Infection Pneumonia. journal1, 2025, 45(5): 41-43.
2025, Vol. 45 
